Download

Download Full Text (193 KB)

Description

The da Vinci SP™ is a single-port robotic surgical system that was FDA approved for urologic and ENT procedures in 2018 in the United States. It was approved for gynecologic use in 2023 in Japan, where the majority of cases have been described but remains non-FDA approved in the US. Due to the novelty of the da Vinci SPTM, there is limited data describing the surgical outcomes and even fewer studies describing gynecologic procedures using the SP robot. To our knowledge, there have been less than 200 gynecology SP cases reported in the literature worldwide with only two of them occurring in the United States at Mayo clinic. Here, we present a novel approach to gynecologic surgery and our initial experience with the da Vinci SP robotic system which will revolutionize the way gynecologic surgery is performed in the future.

Publication Date

5-9-2025

Disciplines

Obstetrics and Gynecology

Comments

2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1710

Da Vinci SP (single port) Surgery: A Novel Approach to Gynecologic Procedures

Share

COinS